Biogen Pharmachem Industries Ltd
Biogen Pharmachem Industries Ltd (531752): company summary
Biogen Pharmachem Industries Ltd (531752) is a micro-cap Financial Services company valued at ₹33 crore operating in Other Financial Services on the NSE and BSE.
Biogen Pharmachem Industries Ltd (531752) is a micro-cap Financial Services company valued at ₹33 crore operating in Other Financial Services on the NSE and BSE.
- Financial performance
- Profit grew 23.2% a year. Return on equity is 0.9%.
- Valuation multiples
- The stock trades at 31.0 times earnings, a premium to the Financial Services median of 21.4, 0.33 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.0) and valuation (7.1), but held back by quality (0.8). Growth looks strong at 9.0, but that is offset by quality at 0.8. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Profit compounding 23% a year
- Loss-making in some of the last 5 years
- Quality is weak (0.8/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Financial Services stocks · Other Financial Services
Explore Biogen Pharmachem Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Biogen Pharmachem Industries Ltd peers in Financial Services
Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.
Compare Biogen Pharmachem Industries Ltd with peers
Related tools & concepts
Value Biogen Pharmachem Industries Ltd with the ratios and calculators DocStoX uses in its analysis.

